Insulin Patch Pumps

  • November 2011
  • -
  • Greystone Research Associates

The collapse of the inhaled insulin market in 2008 has resulted in programs focused on alternative insulin delivery technologies. It now appears that the patch pump – a device that represents the convergence of a transdermal reservoir system with an energy source and control technology – will be the next generation in the evolution in patient-friendly insulin administration. With four FDA-approved insulin patch pump products and twice as many serious development-stage devices, the next 36 months will be critical to market sector participants wishing to ascend to a leadership position in the market segment. With no room for post-market missteps, product reliability, ease-of-use and patient acceptance will be essential for market success.

Highlights

• Analyzes and evaluates insulin patch pump products and development-stage candidates and assesses risks and market potential
• Analyzes insulin patch pump product strategies, technologies and patch development issues
• Provides assessments of insulin patch pump products
• Provides market data and forecasts to 2015
• Profiles market sector participants, their product development activities and business strategies

Table Of Contents

Summary of Contents
Executive Summary

Diabetes Market Dynamics

Shifting Insulin Delivery Markets
Demand Drivers
Demographic Shifts
Managed Care Initiatives
Growth in Home Healthcare
Technology Market Drivers
Competitive Landscape

Patch Pump Device Strategies

Device/System Architecture
Drug Delivery Mechanism
Drug Reservoirs
Sized Patch Pumps
Handheld Remote Electronics
Accuracy and Dosing Variability
Alerts and Patient Notification
Special Features

FDA-Approved Insulin Patch Pumps - Analysis and Market Data

Finesse
OmniPod
Solo
V-Go

Development-Stage Insulin Patch Pumps - Assessments and Forecasts

Cellnovo
CeQur
Freehand
Jewel Pump
Medipacs
PassPort
Sensile Medical
Spring Hybrid Pump
SteadyMed

Market Factors
Regulations
U.S.
International
Trials and Approval
IP and Product Positioning

Sector Participant Company Profiles

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, ...

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most ...

Multiple Sclerosis (MS) Drugs and Biologics : Technologies and Global Markets

Multiple Sclerosis (MS) Drugs and Biologics : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research study offers an overview of the multiple sclerosis (MS) disease-modifying product market, including regulatory issues accompanied by detailed analyses and forecasts by product. Its main ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.